Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

370 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer.
Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, Wu X. Shao L, et al. Among authors: wood cg. J Urol. 2007 Oct;178(4 Pt 1):1492-6. doi: 10.1016/j.juro.2007.05.112. Epub 2007 Aug 16. J Urol. 2007. PMID: 17707063
Tumor-suppressive activity of CD66a in prostate cancer.
Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, Logothetis CJ, Lin SH. Luo W, et al. Among authors: wood cg. Cancer Gene Ther. 1999 Jul-Aug;6(4):313-21. doi: 10.1038/sj.cgt.7700055. Cancer Gene Ther. 1999. PMID: 10419049
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Inoue K, Perrotte P, Wood CG, Slaton JW, Sweeney P, Dinney CP. Inoue K, et al. Among authors: wood cg. Clin Cancer Res. 2000 Nov;6(11):4422-31. Clin Cancer Res. 2000. PMID: 11106263
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.
Inoue K, Wood CG, Slaton JW, Karashima T, Sweeney P, Dinney CP. Inoue K, et al. Among authors: wood cg. Oncol Rep. 2001 Sep-Oct;8(5):955-64. doi: 10.3892/or.8.5.955. Oncol Rep. 2001. PMID: 11496299
G-rich sequence factor 1, a novel marker of prostate cancer virulence identified through mRNA differential display.
Wood CG. Wood CG. Prostate Cancer Prostatic Dis. 1999 Nov;2(S3):S35. doi: 10.1038/sj.pcan.4500360. Prostate Cancer Prostatic Dis. 1999. PMID: 12496814 No abstract available.
Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
Sexton WJ, Wood CG, Kim R, Pisters LL. Sexton WJ, et al. Among authors: wood cg. J Urol. 2003 Apr;169(4):1353-6. doi: 10.1097/ J Urol. 2003. PMID: 12629359
Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands.
Ardelt PU, Wood CG, Chen L, Mintz PJ, Moya C, Arap MA, Wright KC, Pasqualini R, Arap W. Ardelt PU, et al. Among authors: wood cg. J Urol. 2003 Apr;169(4):1535-40. doi: 10.1097/01.ju.0000055477.37115.66. J Urol. 2003. PMID: 12629410
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL. Sweeney P, et al. Among authors: wood cg. J Urol. 2003 Jun;169(6):2113-7. doi: 10.1097/01.ju.0000067601.29966.4a. J Urol. 2003. PMID: 12771730 Clinical Trial.
Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?
Sánchez-Ortiz RF, Tannir N, Ahrar K, Wood CG. Sánchez-Ortiz RF, et al. Among authors: wood cg. J Urol. 2003 Jul;170(1):178-9. doi: 10.1097/01.ju.0000070823.38336.7b. J Urol. 2003. PMID: 12796677 No abstract available.
The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma.
Wood CG. Wood CG. Urol Clin North Am. 2003 Aug;30(3):581-8. doi: 10.1016/s0094-0143(03)00026-0. Urol Clin North Am. 2003. PMID: 12953756 Review.
370 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page